Brookfield Asset Management Inc. Natera, Inc. Transaction History

Brookfield Asset Management Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$34.17 - $47.91 $75,139 - $105,354	-2,199 Reduced 21.03%	8,257 $331,000
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $110,125 - $169,019	2,982 Added 39.9%	10,456 $458,000
Q2 2022 Nov 16, 2022	SELL	$28.13 - $44.54 $83,883 - $132,818	-2,982 Reduced 28.52%	7,474 $265,000
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $454,805 - $720,122	-16,168 Reduced 68.39%	7,474 $264,000
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $150,872 - $454,458	4,976 Added 26.66%	23,642 $961,000
Q4 2021 Feb 14, 2022	BUY	$86.26 - $119.0 $1.02 Million - $1.41 Million	11,855 Added 174.06%	18,666 $1.74 Million
Q3 2021 Nov 16, 2021	BUY	$100.17 - $126.36 $353,700 - $446,177	3,531 Added 107.65%	6,811 $759,000
Q2 2021 Aug 17, 2021	SELL	$86.05 - $119.72 $991,468 - $1.38 Million	-11,522 Reduced 77.84%	3,280 $372,000
Q1 2021 May 17, 2021	SELL	$91.47 - $124.36 $354,812 - $482,392	-3,879 Reduced 20.76%	14,802 $1.5 Million
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $683,664 - $1.15 Million	10,256 Added 121.73%	18,681 $1.86 Million
Q3 2020 Nov 16, 2020	BUY	$45.89 - $72.67 $386,623 - $612,244	8,425 New	8,425 $608,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.